What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study

BACKGROUND: The reduction of overtreatment by active surveillance (AS) is limited in patients with low-risk prostate cancer (PCa) due to high rates of patients switching to radical treatment. MRI improves biopsy accuracy and could therewith affect inclusion in or continuation of AS. We aim to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Luiting, H. B., Remmers, S., Valdagni, R., Boevé, E. R., Staerman, F., Rueb, J., Somford, D. M., Pickles, T., Rannikko, A., Roobol, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616762/
https://www.ncbi.nlm.nih.gov/pubmed/33833378
http://dx.doi.org/10.1038/s41391-021-00343-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616762/
https://www.ncbi.nlm.nih.gov/pubmed/33833378
http://dx.doi.org/10.1038/s41391-021-00343-2

Ejemplares similares